What Happened?
Philadelphia, PA-based Tmunity-Therapeutics Appointed James Riley as Co Founder and Chief Executive Officer
About the Company
Our vision is to become the leading innovative global life-sciences company that unlocks the potential of T-cell biology and combines it with the power of T-cell engineering excellence to provide cures for patients. Through our model of seamless and rapid integration of research, translational medicine, manufacturing science, clinical development and customer-centric approaches, we will design and deliver enhanced state-of-the-art solutions for patients in a host of disease areas using Chimeric Antigen Receptors (CARs), Gene edited T-Cells, T regulatory cells (Treg), and engineered T Cell Receptors (TCRs)
About the Person
James Riley is Co Founder and Chief Executive Officer at Tmunity Therapeutics. Previously, James held various senior HR leadership roles in the industry.
Info Source
News
Short Profile